| Year |
Citation |
Score |
| 2007 |
Levi M, Dempsey DA, Benowitz NL, Sheiner LB. Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model application. Journal of Pharmacokinetics and Pharmacodynamics. 34: 23-34. PMID 17206525 DOI: 10.1007/S10928-006-9026-0 |
0.337 |
|
| 2007 |
Levi M, Dempsey DA, Benowitz NL, Sheiner LB. Population pharmacokinetics of nicotine and its metabolites I. Model development. Journal of Pharmacokinetics and Pharmacodynamics. 34: 5-21. PMID 17206524 DOI: 10.1007/S10928-006-9027-Z |
0.329 |
|
| 2007 |
Kshirsagar SA, Blaschke TF, Sheiner LB, Krygowski M, Acosta EP, Verotta D. Improving data reliability using a non-compliance detection method versus using pharmacokinetic criteria. Journal of Pharmacokinetics and Pharmacodynamics. 34: 35-55. PMID 17004125 DOI: 10.1007/S10928-006-9032-2 |
0.395 |
|
| 2007 |
Nedelman JR, Rubin DB, Sheiner LB. Diagnostics for confounding in PK/PD models for oxcarbazepine. Statistics in Medicine. 26: 290-308. PMID 16615036 DOI: 10.1002/Sim.2542 |
0.315 |
|
| 2005 |
Zhang L, Sheiner LB. Analyzing multi-response data using forcing functions. Journal of Pharmacokinetics and Pharmacodynamics. 32: 283-305. PMID 16283535 DOI: 10.1007/S10928-005-0065-8 |
0.315 |
|
| 2004 |
Soy D, Beal SL, Sheiner LB. Population one-compartment pharmacokinetic analysis with missing dosage data. Clinical Pharmacology and Therapeutics. 76: 441-51. PMID 15536459 DOI: 10.1016/J.Clpt.2004.07.010 |
0.309 |
|
| 2004 |
Kenna LA, Sheiner LB. Estimating treatment effect in the presence of non-compliance measured with error: precision and robustness of data analysis methods. Statistics in Medicine. 23: 3561-80. PMID 15534899 DOI: 10.1002/Sim.1830 |
0.735 |
|
| 2003 |
Zhang L, Beal SL, Sheiner LB. Simultaneous vs. Sequential Analysis for Population PK/PD Data II: Robustness of Methods Journal of Pharmacokinetics and Pharmacodynamics. 30: 405-416. PMID 15000422 DOI: 10.1023/B:Jopa.0000012999.36063.4E |
0.324 |
|
| 2003 |
Zhang L, Beal SL, Sheiner LB. Simultaneous vs. sequential analysis for population PK/PD data I: best-case performance. Journal of Pharmacokinetics and Pharmacodynamics. 30: 387-404. PMID 15000421 DOI: 10.1023/B:Jopa.0000012998.04442.1F |
0.36 |
|
| 2003 |
Peck CC, Rubin DB, Sheiner LB. Hypothesis: a single clinical trial plus causal evidence of effectiveness is sufficient for drug approval. Clinical Pharmacology and Therapeutics. 73: 481-90. PMID 12811358 DOI: 10.1016/S0009-9236(03)00018-3 |
0.307 |
|
| 2003 |
Pfister M, Zhang L, Hammarlund-Udenaes M, Sheiner LB, Gerber CM, Täuber MG, Cottagnoud P. Modeling of transfer kinetics at the serum-cerebrospinal fluid barrier in rabbits with experimental meningitis: application to grepafloxacin. Antimicrobial Agents and Chemotherapy. 47: 138-43. PMID 12499181 DOI: 10.1128/Aac.47.1.138-143.2003 |
0.373 |
|
| 2003 |
Pfister M, Labbé L, Hammer SM, Mellors J, Bennett KK, Rosenkranz S, Sheiner LB. Population pharmacokinetics and pharmacodynamics of efavirenz, nelfinavir, and indinavir: Adult AIDS Clinical Trial Group Study 398. Antimicrobial Agents and Chemotherapy. 47: 130-7. PMID 12499180 DOI: 10.1128/Aac.47.1.130-137.2003 |
0.364 |
|
| 2003 |
Zhang L, Sheiner L. Simultaneous (SIM) vs. Sequential (SEQ) Fitting of a Physiological Flow Model (PFM) to Multivariate Pharmacokinetic (MPK) Data Clinical Pharmacology & Therapeutics. 73: P53-P53. DOI: 10.1016/S0009-9236(03)90550-9 |
0.307 |
|
| 2003 |
Soy D, Beal S, Sheiner L. Population pharmacokinetic analysis with missing dosage data. Clinical Pharmacology & Therapeutics. 73: P21-P21. DOI: 10.1016/S0009-9236(03)90433-4 |
0.302 |
|
| 2002 |
Lu JF, Blaschke TF, Flexner C, Rosenkranz SL, Sheiner LB. Model-based analysis of the pharmacokinetic interactions between ritonavir, nelfinavir, and saquinavir after simultaneous and staggered oral administration. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 30: 1455-61. PMID 12433819 DOI: 10.1124/Dmd.30.12.1455 |
0.31 |
|
| 2002 |
Lu J, Pfister M, Ferrari P, Chen G, Sheiner L. Pharmacokinetic-pharmacodynamic modelling of magnesium plasma concentration and blood pressure in preeclamptic women. Clinical Pharmacokinetics. 41: 1105-13. PMID 12403646 DOI: 10.2165/00003088-200241130-00007 |
0.308 |
|
| 2001 |
Zhang L, Price R, Aweeka F, Bellibas SE, Sheiner LB. Making the most of sparse clinical data by using a predictive-model-based analysis, illustrated with a stavudine pharmacokinetic study European Journal of Pharmaceutical Sciences. 12: 377-385. PMID 11231104 DOI: 10.1016/S0928-0987(00)00158-5 |
0.376 |
|
| 2000 |
Sheiner L, Wakefield J. Population modelling in drug development. Statistical Methods in Medical Research. 8: 183-93. PMID 10636334 DOI: 10.1177/096228029900800302 |
0.377 |
|
| 1999 |
Cox EH, Veyrat-Follet C, Beal SL, Fuseau E, Kenkare S, Sheiner LB. A population pharmacokinetic-pharmacodynamic analysis of repeated measures time-to-event pharmacodynamic responses: The antiemetic effect of ondansetron Journal of Pharmacokinetics and Biopharmaceutics. 27: 625-644. PMID 11153449 DOI: 10.1023/A:1020930626404 |
0.39 |
|
| 1999 |
Gupta SK, Sathyan G, Lindemulder EA, Ho PL, Sheiner LB, Aarons L. Quantitative characterization of therapeutic index: Application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships Clinical Pharmacology and Therapeutics. 65: 672-684. PMID 10391673 DOI: 10.1016/S0009-9236(99)90089-9 |
0.362 |
|
| 1999 |
Zhou XJ, Sheiner LB, D'Aquila RT, Hughes MD, Hirsch MS, Fischl MA, Johnson VA, Myers M, Sommadossi JP. Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators. Antimicrobial Agents and Chemotherapy. 43: 121-8. PMID 9869576 DOI: 10.1128/Aac.43.1.121 |
0.39 |
|
| 1999 |
Kenna LA, Sheiner LB. Calibration of a fallible instrument for measuring patient compliance Clinical Pharmacology and Therapeutics. 65: 182. |
0.703 |
|
| 1998 |
Park K, Verotta D, Gupta SK, Sheiner LB. Use of a pharmacokinetic/pharmacodynamic model to design an optimal dose input profile Journal of Pharmacokinetics and Biopharmaceutics. 26: 471-492. PMID 10214563 DOI: 10.1023/A:1021068202606 |
0.401 |
|
| 1998 |
Girard P, Blaschke TF, Kastrissios H, Sheiner LB. A Markov mixed effect regression model for drug compliance Statistics in Medicine. 17: 2313-2333. PMID 9819830 DOI: 10.1002/(Sici)1097-0258(19981030)17:20<2313::Aid-Sim935>3.0.Co;2-V |
0.377 |
|
| 1998 |
Park K, Verotta D, Gupta SK, Sheiner LB. Passive versus electrotransport-facilitated transdermal absorption of ketorolac Clinical Pharmacology and Therapeutics. 63: 303-315. PMID 9542474 DOI: 10.1016/S0009-9236(98)90162-X |
0.33 |
|
| 1997 |
Vanhove GF, Gries JM, Verotta D, Sheiner LB, Coombs R, Collier AC, Blaschke TF. Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapy Antimicrobial Agents and Chemotherapy. 41: 2433-2438. PMID 9371346 DOI: 10.1128/Aac.41.11.2433 |
0.312 |
|
| 1997 |
Sheiner LB, Beal SL, Dunne A. Analysis of nonrandomly censored ordered categorical longitudinal data from analgesic trials Journal of the American Statistical Association. 92: 1235-1244. DOI: 10.1080/01621459.1997.10473642 |
0.357 |
|
| 1996 |
Girard P, Sheiner LB, Kastrissios H, Blaschke TF. Do we need full compliance data for population pharmacokinetic analysis? Journal of Pharmacokinetics and Biopharmaceutics. 24: 265-282. PMID 8970015 DOI: 10.1007/Bf02353671 |
0.398 |
|
| 1996 |
Fattinger KE, Verotta D, Porchet HC, Munafo A, Le Cotonnec JY, Sheiner LB. Modeling a bivariate control system: LH and testosterone response to the GnRH antagonist antide American Journal of Physiology - Endocrinology and Metabolism. 271. PMID 8897868 DOI: 10.1152/Ajpendo.1996.271.4.E775 |
0.327 |
|
| 1996 |
Bruno R, Vivier N, Vergniol JC, De Phillips SL, Montay G, Sheiner LB. A population pharmacokinetic model for docetaxel (Taxotere): model building and validation. Journal of Pharmacokinetics and Biopharmaceutics. 24: 153-72. PMID 8875345 DOI: 10.1007/Bf02353487 |
0.325 |
|
| 1996 |
Park K, Verotta D, Sheiner L. A nonparametric approach for estimating model independent pharmacokinetic measures from noisy data. Clinical Pharmacology & Therapeutics. 59: 154-154. DOI: 10.1038/Sj.Clpt.1996.115 |
0.36 |
|
| 1995 |
Karlsson MO, Beal SL, Sheiner LB. Three new residual error models for population PK/PD analyses Journal of Pharmacokinetics and Biopharmaceutics. 23: 651-672. PMID 8733951 DOI: 10.1007/Bf02353466 |
0.321 |
|
| 1995 |
Sallas WM, Nedelman JR, Sheiner LB, Meligeni JA, Robinson WT. A nonlinear mixed-effects pharmacokinetic model comparing two formulations of cyclosporine in stable renal transplant patients. Journal of Pharmacokinetics and Biopharmaceutics. 23: 495-514. PMID 8656344 DOI: 10.1007/Bf02353471 |
0.403 |
|
| 1995 |
Verotta D, Sheiner LB. A general conceptual model for non-steady state pharmacokinetic/Pharmacodynamic data Journal of Pharmacokinetics and Biopharmaceutics. 23: 1-4. PMID 8576839 DOI: 10.1007/Bf02353780 |
0.305 |
|
| 1995 |
Karlsson MO, Port RE, Ratain MJ, Sheiner LB. A population model for the leukopenic effect of etoposide Clinical Pharmacology and Therapeutics. 57: 325-334. PMID 7697950 DOI: 10.1016/0009-9236(95)90158-2 |
0.406 |
|
| 1994 |
Sheiner LB. A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data Clinical Pharmacology and Therapeutics. 56: 309-322. PMID 7924127 DOI: 10.1038/Clpt.1994.142 |
0.318 |
|
| 1994 |
Troconiz IF, Sheiner LB, Verotta D. Semiparametric models for antagonistic drug interactions Journal of Applied Physiology. 76: 2224-2233. PMID 7914889 DOI: 10.1152/Jappl.1994.76.5.2224 |
0.352 |
|
| 1994 |
Ludden TM, Beal SL, Sheiner LB. Comparison of the Akaike Information Criterion, the Schwarz criterion and the F test as guides to model selection Journal of Pharmacokinetics and Biopharmaceutics. 22: 431-445. PMID 7791040 DOI: 10.1007/Bf02353864 |
0.334 |
|
| 1993 |
Rutledge GW, Thomsen GE, Farr BR, Tovar MA, Polaschek JX, Beinlich IA, Sheiner LB, Fagan LM. The design and implementation of a ventilator-management advisor Artificial Intelligence in Medicine. 5: 67-82. PMID 8358487 DOI: 10.1016/0933-3657(93)90006-O |
0.306 |
|
| 1993 |
Karlsson MO, Sheiner LB. The importance of modeling interoccasion variability in population pharmacokinetic analyses Journal of Pharmacokinetics and Biopharmaceutics. 21: 735-750. PMID 8138894 DOI: 10.1007/Bf01113502 |
0.397 |
|
| 1993 |
Holford N, Hashimoto Y, Sheiner LB. Time and Theophylline Concentration Help Explain the Recovery of Peak Flow Following Acute Airways Obstruction: Population Analysis of a Randomised Concentration Controlled Trial Clinical Pharmacokinetics. 25: 506-515. PMID 8119050 DOI: 10.2165/00003088-199325060-00008 |
0.301 |
|
| 1992 |
Uehlinger DE, Gotch FA, Sheiner LB. A pharmacodynamic model of erythropoietin therapy for uremic anemia. Clinical Pharmacology and Therapeutics. 51: 76-89. PMID 1732079 DOI: 10.1038/Clpt.1992.10 |
0.378 |
|
| 1992 |
Lenert LA, Lurie J, Sheiner LB, Coleman R, Klostermann H, Blaschke TF. Advanced computer programs for drug dosing that combine pharmacokinetic and symbolic modeling of patients Computers and Biomedical Research. 25: 29-42. PMID 1547625 DOI: 10.1016/0010-4809(92)90033-7 |
0.352 |
|
| 1992 |
Mandema JW, Verotta D, Sheiner LB. Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects Journal of Pharmacokinetics and Biopharmaceutics. 20: 511-528. PMID 1287200 DOI: 10.1007/Bf01061469 |
0.356 |
|
| 1991 |
Sheiner LB, Hashimoto Y, Beal SL. A simulation study comparing designs for dose ranging Statistics in Medicine. 10: 303-321. PMID 2028115 DOI: 10.1002/Sim.4780100303 |
0.346 |
|
| 1991 |
Sambol NC, Sheiner LB. Population dose versus response of betaxolol and atenolol: A comparison of potency and variability Clinical Pharmacology and Therapeutics. 49: 24-31. PMID 1988237 DOI: 10.1038/Clpt.1991.5 |
0.35 |
|
| 1991 |
Kahn MG, Fagan LM, Sheiner LB. Combining physiologic models and symbolic methods to interpret time-varying patient data. Methods of Information in Medicine. 30: 167-78. PMID 1943788 DOI: 10.1055/S-0038-1634833 |
0.313 |
|
| 1991 |
Hashimoto Y, Sheiner LB. Designs for population pharmacodynamics: Value of pharmacokinetic data and population analysis Journal of Pharmacokinetics and Biopharmaceutics. 19: 333-353. PMID 1875286 DOI: 10.1007/Bf03036255 |
0.335 |
|
| 1991 |
Verotta D, Sheiner LB, Beal SL. Mean time parameters for generalized physiological flow models (semihomogeneous linear systems) Journal of Pharmacokinetics and Biopharmaceutics. 19: 319-331. PMID 1875285 DOI: 10.1007/Bf03036254 |
0.308 |
|
| 1991 |
Verotta D, Sheiner LB. Semiparametric analysis of non-steady-state pharmacodynamic data Journal of Pharmacokinetics and Biopharmaceutics. 19: 691-712. PMID 1815048 DOI: 10.1007/Bf01080874 |
0.33 |
|
| 1991 |
Hale VG, Aizawa K, Sheiner LB, Benet LZ. Disposition of prednisone and prednisolone in the perfused rabbit liver: Modeling hepatic metabolic processes Journal of Pharmacokinetics and Biopharmaceutics. 19: 597-614. PMID 1783993 DOI: 10.1007/Bf01062965 |
0.353 |
|
| 1991 |
Verotta D, Kitts J, Rodriguez R, Coldwell J, Miller RD, Sheiner LB. Reversal of neuromuscular blockade in humans by neostigmine and edrophonium: A mathematical model Journal of Pharmacokinetics and Biopharmaceutics. 19: 713-729. PMID 1687690 DOI: 10.1007/Bf01080875 |
0.345 |
|
| 1991 |
Sambol NC, Clementi WA, Sheiner LB. Population dose-response relationships determined from efficacy trials: The antihypertensive effect of atenolol and betaxolol Journal of Pharmacokinetics and Biopharmaceutics. 19. DOI: 10.1007/Bf01371010 |
0.319 |
|
| 1991 |
Grasela TH, Sheiner LB. Pharmacostatistical modeling for observational data Journal of Pharmacokinetics and Biopharmaceutics. 19. DOI: 10.1007/Bf01371006 |
0.353 |
|
| 1991 |
Sheiner LB, Grasela TH. An introduction to mixed effect modeling: Concepts, definitions, and justification Journal of Pharmacokinetics and Biopharmaceutics. 19. DOI: 10.1007/Bf01371005 |
0.382 |
|
| 1989 |
Sheiner LB, Beal SL, Sambol NC. Study designs for dose-ranging Clinical Pharmacology and Therapeutics. 46: 63-77. PMID 2743708 DOI: 10.1038/Clpt.1989.108 |
0.348 |
|
| 1988 |
Sheiner LB, Beal SL. Commentary on "extended least squares (ELS) for pharmacokinetic models" Journal of Pharmaceutical Sciences. 77: 731-732. PMID 3210166 DOI: 10.1002/Jps.2600770820 |
0.338 |
|
| 1987 |
Carpenter RL, Eger RI, Johnson BH, Unadkat JD, Sheiner LB. Does the duration of anesthetic administration affect the pharmacokinetics or metabolism of inhaled anesthetics in humans? Anesthesia and Analgesia. 66: 1-8. PMID 3800013 DOI: 10.1213/00000539-198701000-00001 |
0.351 |
|
| 1987 |
Sheiner LB, Beal SL. A note on confidence intervals with extended least squares parameter estimates Journal of Pharmacokinetics and Biopharmaceutics. 15: 93-98. PMID 3625482 DOI: 10.1007/Bf01062941 |
0.358 |
|
| 1987 |
Verotta D, Sheiner LB. Simultaneous modeling of pharmacokinetics and pharmacodynamics: An improved algorithm Bioinformatics. 3: 345-349. PMID 2898970 DOI: 10.1093/Bioinformatics/3.4.345 |
0.327 |
|
| 1987 |
Sheiner LB. Commentary to pharmacokinetic/pharmacodynamic modeling: What it is! Journal of Pharmacokinetics and Biopharmaceutics. 15: 553-555. DOI: 10.1007/Bf01061763 |
0.331 |
|
| 1986 |
Sheiner LB. Analysis of pharmacokinetic data using parametric models. III. Hypothesis tests and confidence intervals Journal of Pharmacokinetics and Biopharmaceutics. 14: 539-555. PMID 3806375 DOI: 10.1007/Bf01059660 |
0.346 |
|
| 1986 |
Unadkat JD, Sheiner LB, Hennis PJ, Cronnelly R, Miller RD, Sharma M. An integrated model for the interaction of muscle relaxants with their antagonists Journal of Applied Physiology. 61: 1593-1598. PMID 3781972 DOI: 10.1152/Jappl.1986.61.4.1593 |
0.312 |
|
| 1986 |
Unadkat JD, Bartha F, Sheiner LB. Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models Clinical Pharmacology and Therapeutics. 40: 86-93. PMID 3720181 DOI: 10.1038/Clpt.1986.143 |
0.347 |
|
| 1986 |
Carpenter RL, Eger EI, Johnson BH, Unadkat JD, Sheiner LB. Pharmacokinetics of Inhaled Anesthetics in Humans Anesthesia & Analgesia. 65: 575???582. DOI: 10.1213/00000539-198606000-00004 |
0.331 |
|
| 1985 |
Sheiner LB. Analysis of pharmacokinetic data using parametric models. II. Point estimates of an individual's parameters Journal of Pharmacokinetics and Biopharmaceutics. 13: 515-540. PMID 3834066 DOI: 10.1007/Bf01059333 |
0.357 |
|
| 1984 |
Sheiner LB. Analysis of pharmacokinetic data using parametric models-1: Regression models Journal of Pharmacokinetics and Biopharmaceutics. 12: 93-117. PMID 6747821 DOI: 10.1007/Bf01063613 |
0.364 |
|
| 1984 |
Sheiner LB. The population approach to pharmacokinetic data analysis: Rationale and standard data analysis methods Drug Metabolism Reviews. 15: 153-171. PMID 6745080 DOI: 10.3109/03602538409015063 |
0.394 |
|
| 1984 |
Sheiner LB, Grasela TH. Experience with nonmem: Analysis of routine phenytoin clinical pharmacokinetic data Drug Metabolism Reviews. 15: 293-303. PMID 6547663 DOI: 10.3109/03602538409015067 |
0.391 |
|
| 1984 |
Peck CC, Beal SL, Sheiner LB, Nichols AI. Extended least squares nonlinear regression: A possible solution to the "choice of weights" problem in analysis of individual pharmacokinetic data Journal of Pharmacokinetics and Biopharmaceutics. 12: 545-558. PMID 6520748 DOI: 10.1007/Bf01060132 |
0.315 |
|
| 1984 |
Grasela TH, Sheiner LB. Population Pharmacokinetics of Procainamide from Routine Clinical Data Clinical Pharmacokinetics. 9: 545-554. PMID 6509861 DOI: 10.2165/00003088-198409060-00004 |
0.356 |
|
| 1984 |
Guy RH, Tur E, Bugatto B, Gaebel C, Sheiner LB, Maibach HI. Pharmacodynamic Measurements of Methyl Nicotinate Percutaneous Absorption Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 1: 76-81. DOI: 10.1023/A:1016303414902 |
0.335 |
|
| 1983 |
Sheiner LB, Beal SL. Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: Routine clinical pharmacokinetic data Journal of Pharmacokinetics and Biopharmaceutics. 11: 303-319. PMID 6644555 DOI: 10.1007/Bf01061870 |
0.39 |
|
| 1983 |
Grasela TH, Sheiner LB, Rambeck B, Boenigk HE, Dunlop A, Mullen PW, Wadsworth J, Richens A, Ishizaki T, Chiba K, Miura H, Minagawa K, Blain PG, Mucklow JC, Bacon CT, et al. Steady-state Pharmacokinetics of Phenytoin from Routinely Collected Patient Data Clinical Pharmacokinetics. 8: 355-364. PMID 6617043 DOI: 10.2165/00003088-198308040-00006 |
0.345 |
|
| 1982 |
Sheiner LB, Beal SL. Bayesian individualization of pharmacokinetics: Simple implementation and comparison with non-Bayesian methods Journal of Pharmaceutical Sciences. 71: 1344-1348. PMID 7153881 DOI: 10.1002/Jps.2600711209 |
0.382 |
|
| 1981 |
Sheiner LB, Beal SL. Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic data Journal of Pharmacokinetics and Biopharmaceutics. 9: 635-651. PMID 7334463 DOI: 10.1007/Bf01061030 |
0.384 |
|
| 1981 |
Vozeh S, Muir KT, Sheiner LB, Follath F. Predicting individual phenytoin dosage Journal of Pharmacokinetics and Biopharmaceutics. 9: 131-146. PMID 7277205 DOI: 10.1007/Bf01068078 |
0.339 |
|
| 1981 |
Holford NH, Coates PE, Guentert TW, Riegelman S, Sheiner LB. The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration--effect relationships. British Journal of Clinical Pharmacology. 11: 187-95. PMID 7213522 DOI: 10.1111/J.1365-2125.1981.Tb01123.X |
0.333 |
|
| 1981 |
Holford NHG, Sheiner LB. Understanding the Dose-Effect Relationship: Clinical Application of Pharmacokinetic-Pharmacodynamic Models Clinical Pharmacokinetics. 6: 429-453. PMID 7032803 DOI: 10.2165/00003088-198106060-00002 |
0.391 |
|
| 1981 |
Sheiner LB, Benet LZ, Pagliaro LA. A standard approach to compiling clinical pharmacokinetic data Journal of Pharmacokinetics and Biopharmaceutics. 9: 59-127. PMID 7014827 DOI: 10.1007/Bf01059343 |
0.374 |
|
| 1980 |
Stanski DR, Ham J, Miller RD, Sheiner LB. Time-dependent increase in sensitivity to d-tubocurarine during enflurane anesthesia in man Anesthesiology. 52: 483-487. PMID 7377594 DOI: 10.1097/00000542-198006000-00005 |
0.303 |
|
| 1980 |
Whiting B, Holford NH, Sheiner LB. Quantitative analysis of the disopyramide concentration-effect relationship. British Journal of Clinical Pharmacology. 9: 67-75. PMID 7356895 DOI: 10.1111/J.1365-2125.1980.Tb04799.X |
0.36 |
|
| 1980 |
Sheiner LB, Beal SL. Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic data Journal of Pharmacokinetics and Biopharmaceutics. 8: 553-571. PMID 7229908 DOI: 10.1007/Bf01060053 |
0.396 |
|
| 1979 |
Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J. Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine Clinical Pharmacology and Therapeutics. 25: 358-371. PMID 761446 DOI: 10.1097/00132586-198002000-00012 |
0.384 |
|
| 1979 |
Sheiner LB, Beal S, Rosenberg B, Marathe VV. Forecasting individual pharmacokinetics Clinical Pharmacology and Therapeutics. 26: 294-305. PMID 466923 DOI: 10.1002/Cpt1979263294 |
0.313 |
|
| 1979 |
Ham J, Miller RD, Sheiner LB, Matteo RS. Dosage schedule independence of d-tubocurarine pharmacokinetics and pharmacodynamics, and recovery of neuromuscular function Anesthesiology. 50: 528-533. PMID 453578 DOI: 10.1097/00000542-197906000-00011 |
0.329 |
|
| 1979 |
Wheeler LA, Sheiner LB. Clinical estimation of creatinine clearance American Journal of Clinical Pathology. 72: 27-31. PMID 453108 DOI: 10.1093/Ajcp/72.1.27 |
0.345 |
|
| 1977 |
Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data Journal of Pharmacokinetics and Biopharmaceutics. 5: 445-479. PMID 925881 DOI: 10.1007/Bf01061728 |
0.392 |
|
| 1977 |
Martin E, Tozer TN, Sheiner LB, Riegelman S. The clinical pharmacokinetics of phenytoin. Journal of Pharmacokinetics and Biopharmaceutics. 5: 579-96. PMID 599408 DOI: 10.1007/Bf01059685 |
0.364 |
|
| 1977 |
Wheeler LA, Sheiner LB, Melmon KL. Pharmacokinetics of Lidocaine Jama: the Journal of the American Medical Association. 237: 1433-1434. DOI: 10.1001/Jama.1977.03270410033006 |
0.319 |
|
| 1976 |
Wheeler LA, Sheiner LB. A general method for optimal drug dose computation Journal of Pharmacokinetics and Biopharmaceutics. 4: 487-497. PMID 1011075 DOI: 10.1007/Bf01064554 |
0.347 |
|
| 1975 |
Sheiner LB, Halkin H, Peck C, Rosenberg B, Melmon KL. Improved computer-assisted digoxin therapy. A method using feedback of measured serum digoxin concentrations Annals of Internal Medicine. 82: 619-627. PMID 1137256 DOI: 10.7326/0003-4819-82-5-619 |
0.301 |
|
| 1974 |
Sheiner LB, Rosenberg B, Marathe VV, Peck C. Differences in serum digoxin concentrations between outpatients and inpatients: An effect o compliance? Clinical Pharmacology and Therapeutics. 15: 239-246. PMID 4593118 DOI: 10.1002/Cpt1974153239 |
0.365 |
|
| 1973 |
Peck CC, Sheiner LB, Martin CM, Combs DT, Melmon KL. Computer-assisted digoxin therapy New England Journal of Medicine. 289: 441-446. PMID 4763409 DOI: 10.1056/Nejm197308302890902 |
0.315 |
|
| 1973 |
Sanchez N, Sheiner LB, Halkin H, Melmon KL. Pharmacokinetics of digoxin: interpreting bioavailability. British Medical Journal. 4: 132-4. PMID 4752307 DOI: 10.1136/Bmj.4.5885.132 |
0.334 |
|
| 1972 |
Sheiner LB, Rosenberg B, Melmon KL. Modelling of individual pharmacokinetics for computer-aided drug dosage Computers and Biomedical Research. 5: 441-459. PMID 4634367 DOI: 10.1016/0010-4809(72)90051-1 |
0.386 |
|
| Show low-probability matches. |